Neurological Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Perspectives and New Development

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of multiple malignancies, especially in non-small cell lung cancer (NSCLC). With the extensive application of ICIs in clinical practice, clinicians have to manage their toxicities, which are often termed immune-related adverse eve...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Ke, Wang, Yuqing, Zhou, Yuwen, Xia, Ruolan, Tang, Liansha, Liu, Jiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637700/
https://www.ncbi.nlm.nih.gov/pubmed/34866959
http://dx.doi.org/10.1177/11795549211056261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637700/
https://www.ncbi.nlm.nih.gov/pubmed/34866959
http://dx.doi.org/10.1177/11795549211056261

Ejemplares similares